{"id":"novel-treatment","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is complex and involves multiple steps, but it ultimately leads to a reduction in disease symptoms.","oneSentence":"This novel treatment works by targeting a specific molecular pathway to produce a therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:57:46.308Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer, PD-L1 positive"},{"name":"Metastatic non-small cell lung cancer, PD-L1 negative"}]},"trialDetails":[{"nctId":"NCT02194881","phase":"","title":"Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2014-10","conditions":"Cystic Fibrosis","enrollment":57},{"nctId":"NCT02466971","phase":"PHASE3","title":"Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-05-10","conditions":"Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma","enrollment":450},{"nctId":"NCT03188900","phase":"","title":"Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-12","conditions":"Preeclampsia","enrollment":236},{"nctId":"NCT02436707","phase":"PHASE2","title":"Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2015-10-27","conditions":"Lymphoma","enrollment":129},{"nctId":"NCT05053971","phase":"PHASE1, PHASE2","title":"Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-16","conditions":"Advanced Malignant Solid Neoplasm, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma","enrollment":49},{"nctId":"NCT07494305","phase":"PHASE2","title":"Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.","status":"RECRUITING","sponsor":"LB Pharmaceuticals Inc.","startDate":"2026-01-23","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT04967677","phase":"","title":"Establishing of the Inter-rater Reliability and Variability of Selected Standardized Tests Performed in Czech Language","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2021-05-31","conditions":"Motor Activity","enrollment":30},{"nctId":"NCT07170033","phase":"NA","title":"The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Istanbul Health and Technology University","startDate":"2024-05-06","conditions":"Rheumatoid Arthritis","enrollment":49},{"nctId":"NCT03798678","phase":"PHASE1","title":"CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-08","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":36},{"nctId":"NCT03620019","phase":"PHASE2","title":"Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2018-09-10","conditions":"Melanoma Stage Iii, Melanoma Stage Iv, Melanoma","enrollment":25},{"nctId":"NCT06869447","phase":"NA","title":"New York Better Breathing Study","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-04-15","conditions":"Localized Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":100},{"nctId":"NCT07495267","phase":"NA","title":"Nutritional Ketosis Marfan","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-03-13","conditions":"Marfan Syndrome, Aortic Dissection","enrollment":15},{"nctId":"NCT06669299","phase":"NA","title":"Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2025-06-12","conditions":"Ventricular Tachycardia (VT)","enrollment":51},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT05859347","phase":"NA","title":"Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-05-15","conditions":"Cannabis Use Disorder","enrollment":46},{"nctId":"NCT06995898","phase":"NA","title":"The Vanguard Study: Testing a New Way to Screen for Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-16","conditions":"Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma","enrollment":24000},{"nctId":"NCT04579224","phase":"PHASE3","title":"Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-06-28","conditions":"Metastatic Bladder Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma","enrollment":184},{"nctId":"NCT04216719","phase":"NA","title":"Facilitating Opioid Care Connections","status":"ENROLLING_BY_INVITATION","sponsor":"New York State Psychiatric Institute","startDate":"2020-03-18","conditions":"Opioid Court Model, Medication to Treat Opioid Use Disorder, Opioid Use","enrollment":3440},{"nctId":"NCT06854458","phase":"NA","title":"The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-06-27","conditions":"Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging, Myocardial Blood Flow","enrollment":1000},{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT07494513","phase":"NA","title":"Milieu Teaching-AV: Adaptation of Milieu Teaching That Encourages Looking to the Mouth","status":"NOT_YET_RECRUITING","sponsor":"Father Flanagan's Boys' Home","startDate":"2026-04","conditions":"Autism, Autism Spectrum Disorder, Autism, Susceptibility to, 6","enrollment":60},{"nctId":"NCT07496320","phase":"NA","title":"Critical Food Ingredients on Immunocompetence to Prevent the Risk and Development of Obesity/Metabolic Syndrome","status":"COMPLETED","sponsor":"IMDEA Food","startDate":"2024-10-23","conditions":"Immunological Status, Healthy Volunteers, Healthy Volunteers - Male and Female","enrollment":60},{"nctId":"NCT05419024","phase":"PHASE2","title":"Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-09","conditions":"HIV","enrollment":50},{"nctId":"NCT04172532","phase":"PHASE1, PHASE2","title":"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-11","conditions":"Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8","enrollment":92},{"nctId":"NCT06672146","phase":"PHASE2","title":"Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-05-16","conditions":"Acute Myeloid Leukemia","enrollment":93},{"nctId":"NCT03984448","phase":"PHASE2, PHASE3","title":"Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-22","conditions":"Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma","enrollment":363},{"nctId":"NCT04071223","phase":"PHASE2","title":"Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-29","conditions":"Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma","enrollment":134},{"nctId":"NCT03737981","phase":"PHASE3","title":"Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-01-31","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","enrollment":465},{"nctId":"NCT05063565","phase":"PHASE2","title":"TheraSphere With Durvalumab and Tremelimumab for HCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2023-11-03","conditions":"Hepatocellular Carcinoma","enrollment":100},{"nctId":"NCT07398898","phase":"NA","title":"Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2026-03-01","conditions":"Dental Anxiety, Music Therapy, Oral Surgical Procedures","enrollment":250},{"nctId":"NCT07141888","phase":"NA","title":"The Effects of a Probiotic Food Supplement in Hyperuricaemia","status":"RECRUITING","sponsor":"Örebro University, Sweden","startDate":"2025-12-16","conditions":"Hyperuricemia With or Without Gout","enrollment":99},{"nctId":"NCT07102914","phase":"NA","title":"Brief Intervention at Adult Education","status":"ENROLLING_BY_INVITATION","sponsor":"Yale University","startDate":"2025-12-09","conditions":"Behavioral Health Challenges","enrollment":340},{"nctId":"NCT03041688","phase":"PHASE1","title":"Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-02-08","conditions":"Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":58},{"nctId":"NCT06957314","phase":"NA","title":"A Study of Hospital-at-Home for People Receiving Tarlatamab","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-04-23","conditions":"Small-cell Lung Cancer, Small Cell Lung Carcinoma","enrollment":70},{"nctId":"NCT05554406","phase":"PHASE2","title":"Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-09-25","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":335},{"nctId":"NCT03047213","phase":"PHASE2","title":"Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-08-24","conditions":"Locally Advanced Bladder Urothelial Carcinoma, Metastatic Transitional Cell Carcinoma, Metastatic Urothelial Carcinoma","enrollment":17},{"nctId":"NCT05019716","phase":"PHASE1, PHASE2","title":"Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-07-13","conditions":"Advanced NUT Carcinoma, Metastatic NUT Carcinoma, Unresectable NUT Carcinoma","enrollment":36},{"nctId":"NCT07495345","phase":"NA","title":"Feasibility Study of a Novel Automated Slit Lamp Camera (Lightfield Medical Ophthalmic Camera Model Vscan001)","status":"COMPLETED","sponsor":"Lightfield Medical","startDate":"2023-07-01","conditions":"Anterior Segment of Eye","enrollment":54},{"nctId":"NCT06800209","phase":"PHASE2","title":"Pain Reprocessing Therapy in Post-Operative Knee Pain","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-08-13","conditions":"Pain, Chronic, Knee Pain Chronic","enrollment":110},{"nctId":"NCT07446998","phase":"PHASE2","title":"Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss","status":"RECRUITING","sponsor":"Veru Inc.","startDate":"2026-03","conditions":"Obesity & Overweight, Mobility Disability, HOMA-IR","enrollment":200},{"nctId":"NCT04868032","phase":"NA","title":"Gaining Optimism After Weight Loss Surgery (GOALS) II","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2022-07-01","conditions":"Bariatric Surgery","enrollment":58},{"nctId":"NCT03811002","phase":"PHASE3","title":"Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-26","conditions":"Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":544},{"nctId":"NCT04068194","phase":"PHASE1, PHASE2","title":"Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-04-07","conditions":"Locally Advanced Malignant Solid Neoplasm, Locally Advanced Unresectable Cholangiocarcinoma, Locally Advanced Unresectable Gallbladder Carcinoma","enrollment":103},{"nctId":"NCT07416188","phase":"PHASE1, PHASE2","title":"Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-04-01","conditions":"Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Relapsed Cancer","enrollment":40},{"nctId":"NCT05189470","phase":"NA","title":"Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2022-03-10","conditions":"Diabetic Foot Ulcer, Diabetes, Foot Ulcer","enrollment":100},{"nctId":"NCT06832774","phase":"PHASE2","title":"Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients","status":"RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2025-08-01","conditions":"Prostate Cancer Metastatic Disease","enrollment":192},{"nctId":"NCT06080464","phase":"NA","title":"Clinician Satisfaction With the VERABAND™","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-06-09","conditions":"Chronic Low-back Pain","enrollment":360},{"nctId":"NCT07407140","phase":"PHASE3","title":"VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-04-30","conditions":"AML, Adult","enrollment":300},{"nctId":"NCT06854393","phase":"PHASE2","title":"Lacripep for Corneal Wound Healing Study","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2025-05-23","conditions":"Corneal Epithelial Wound Healing","enrollment":88},{"nctId":"NCT05433025","phase":"NA","title":"A Novel Device for Neck Pain in Active-duty Military Personnel With Forward Head Posture.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kessler Foundation","startDate":"2022-06-20","conditions":"Neck Pain","enrollment":40},{"nctId":"NCT05699525","phase":"NA","title":"Personalized Mobile Cognitive Behavioral Therapy Application","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2024-08-02","conditions":"Anxiety Disorders and Symptoms, Depression, Bipolar Disorder","enrollment":100},{"nctId":"NCT07151612","phase":"PHASE4","title":"The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia","status":"COMPLETED","sponsor":"Shanxi Eye Hospital","startDate":"2025-09-04","conditions":"Presbyopia","enrollment":62},{"nctId":"NCT06441604","phase":"PHASE2","title":"Extended-release Buprenorphine as a Novel Low-dose Induction Strategy","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-27","conditions":"Opioid Use Disorder","enrollment":30},{"nctId":"NCT07149870","phase":"NA","title":"Pain Management Teams Using Whole Health to Optimize Function and Safety in Veterans: The TEAMWORK Trial","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-11-20","conditions":"Chronic Pain","enrollment":432},{"nctId":"NCT07488611","phase":"PHASE3","title":"PROGAIN Trial in Gastric Cancer Surgery","status":"RECRUITING","sponsor":"Soonchunhyang University Hospital","startDate":"2026-02-13","conditions":"Stomach (Gastric) Cancer","enrollment":100},{"nctId":"NCT02362750","phase":"","title":"Evaluating Cancer Survivorship Care Models","status":"COMPLETED","sponsor":"George Washington University","startDate":"2013-07","conditions":"Quality of Life, Cancer","enrollment":991},{"nctId":"NCT05510908","phase":"","title":"Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2023-07-25","conditions":"HIV-Associated Malignant Neoplasm, HIV Infections, Cancer","enrollment":460},{"nctId":"NCT06476678","phase":"","title":"Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2024-10-15","conditions":"Esophageal Neoplasm, Esophageal Polyp, Endoscopic Submucosal Dissection","enrollment":50},{"nctId":"NCT07426224","phase":"","title":"Blood Glucose Screening in Patients With Advanced Periodontits: the Role of Specialist Periodontal Care in Identifying Hyperglycaemia and Supporting Patient Centered Treatment","status":"ENROLLING_BY_INVITATION","sponsor":"Folktandvården Stockholms län AB","startDate":"2026-03-13","conditions":"Periodontitis Stage III, Periodontitis Stage IV, Diabetes (DM)","enrollment":300},{"nctId":"NCT07226661","phase":"PHASE2","title":"Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder","status":"RECRUITING","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2026-01-19","conditions":"Major Depressive Disorder (MDD)","enrollment":230},{"nctId":"NCT05119413","phase":"PHASE2","title":"Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2021-11-30","conditions":"Melanosis","enrollment":40},{"nctId":"NCT05929703","phase":"NA","title":"Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2023-12-04","conditions":"Delirium, Neurocognitive Disorders, Mild Cognitive Impairment","enrollment":1900},{"nctId":"NCT07490509","phase":"PHASE4","title":"Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Poitiers University Hospital","startDate":"2026-04","conditions":"Abemaciclib, Abemaciclib-related Diarrhea, Breast Cancer","enrollment":235},{"nctId":"NCT07161466","phase":"NA","title":"Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2025-08-30","conditions":"Dynamic Lung Compliance, Alveolar Recruitment Maneuver","enrollment":101},{"nctId":"NCT06860867","phase":"NA","title":"PerQdisc Traditional Feasibility Trial.","status":"RECRUITING","sponsor":"Spinal Stabilization Technologies","startDate":"2025-01-10","conditions":"Discogenic Low Back Pain","enrollment":5},{"nctId":"NCT07373496","phase":"","title":"Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-30","conditions":"Radiotherapy, Radiotherapy, Image-Guided","enrollment":20},{"nctId":"NCT07235293","phase":"PHASE2","title":"A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.","status":"RECRUITING","sponsor":"Kahr Bio Australia Pty Ltd","startDate":"2026-01-16","conditions":"Colorectal Cancer","enrollment":90},{"nctId":"NCT01385176","phase":"NA","title":"Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2011-09-21","conditions":"Heart Failure, Congestive Heart Failure","enrollment":118},{"nctId":"NCT07489443","phase":"NA","title":"Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-04","conditions":"Perinatal, Cannabis Use, Tobacco Use","enrollment":25},{"nctId":"NCT07462390","phase":"NA","title":"Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Readmission in Transrectal Ultrasound-Guided Prostate Biopsy","status":"WITHDRAWN","sponsor":"Tarsus University","startDate":"2026-03-03","conditions":"TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY","enrollment":""},{"nctId":"NCT05562557","phase":"NA","title":"A Regional Partnership to Improve Outcomes Through Fatherhood Engagement","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2023-05-09","conditions":"Substance Use, Child Abuse, Child Neglect","enrollment":240},{"nctId":"NCT06998121","phase":"NA","title":"The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transrectal Ultrasonography Guided Prostate Biopsy","status":"RECRUITING","sponsor":"Mersin University","startDate":"2025-06-01","conditions":"Prostate Cancer","enrollment":84},{"nctId":"NCT05727020","phase":"","title":"Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2022-12-15","conditions":"PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer","enrollment":1005},{"nctId":"NCT06134687","phase":"NA","title":"Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2024-06-04","conditions":"Gastrointestinal Neoplasm","enrollment":66},{"nctId":"NCT07119229","phase":"NA","title":"A Multi Center Study Testing a New Implant for Adults With Severe Emphysema","status":"NOT_YET_RECRUITING","sponsor":"Pulmair Medical, Inc.","startDate":"2026-03","conditions":"Emphysema or COPD, Emphysema, COPD","enrollment":60},{"nctId":"NCT00098072","phase":"PHASE1","title":"Endothelial Cell Dysfunction in Pulmonary Hypertension","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2000-05-17","conditions":"Secondary Pulmonary Arterial Hypertension","enrollment":27},{"nctId":"NCT06864936","phase":"NA","title":"Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-05-01","conditions":"Multiple Sclerosis (MS) - Relapsing-remitting","enrollment":30},{"nctId":"NCT07300514","phase":"PHASE3","title":"Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Maintenance Treatment of Peripheral T-cell Lymphoma","enrollment":136},{"nctId":"NCT07028372","phase":"","title":"Long Term Follow-up of Cardiac Arrest Survivors Exposed to Ultra-rapid Cooling","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-06-11","conditions":"Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol","enrollment":12},{"nctId":"NCT06712563","phase":"","title":"Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-04-17","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":2000},{"nctId":"NCT07352930","phase":"NA","title":"A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-04-01","conditions":"Breast-Conserving Surgery","enrollment":172},{"nctId":"NCT06323044","phase":"NA","title":"MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2025-02-11","conditions":"Acute Lymphoblastic Leukemia","enrollment":150},{"nctId":"NCT04271202","phase":"PHASE4","title":"Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-07-29","conditions":"Chronic Migraine","enrollment":64},{"nctId":"NCT06694363","phase":"","title":"New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-06-26","conditions":"Activated PI3K Delta Syndrome","enrollment":14},{"nctId":"NCT06278974","phase":"","title":"Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K","status":"RECRUITING","sponsor":"He Eye Hospital","startDate":"2023-11-10","conditions":"Myopia, Cost-effectiveness Analysis, Quality of Life","enrollment":90},{"nctId":"NCT07469176","phase":"NA","title":"Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Northwestern University","startDate":"2026-05-30","conditions":"Depression","enrollment":72},{"nctId":"NCT05467891","phase":"PHASE2","title":"Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer","status":"RECRUITING","sponsor":"Oana Danciu","startDate":"2022-09-13","conditions":"Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":200},{"nctId":"NCT05439655","phase":"NA","title":"Acute Recording of Stereotyped High-Frequency Oscillations","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-09-01","conditions":"Epilepsy","enrollment":12},{"nctId":"NCT07488624","phase":"","title":"Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Tailoring Adjuvant Therapy in ESCC After Neoadjuvant Chemoimmunotherapy.","status":"COMPLETED","sponsor":"Sichuan University","startDate":"2025-09-01","conditions":"ESCC","enrollment":414},{"nctId":"NCT06220656","phase":"NA","title":"TRAIL Study: Feasibility and Pilot","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2025-05-01","conditions":"Thyroid Nodule, Thyroid Neoplasms, Thyroid Cancer","enrollment":20},{"nctId":"NCT07126990","phase":"PHASE1, PHASE2","title":"Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma","status":"ENROLLING_BY_INVITATION","sponsor":"Xiaorong Wu","startDate":"2025-02-12","conditions":"Glioma","enrollment":40},{"nctId":"NCT06898138","phase":"NA","title":"Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04-01","conditions":"Epilepsy","enrollment":8},{"nctId":"NCT05524311","phase":"PHASE2","title":"Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-10","conditions":"Juvenile Dermatomyositis","enrollment":16},{"nctId":"NCT07282444","phase":"NA","title":"A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-07-01","conditions":"Lung Carcinoma, Head and Neck Carcinoma","enrollment":194},{"nctId":"NCT07487519","phase":"PHASE2","title":"Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Henlius Biotech","startDate":"2026-04-25","conditions":"Breast Cancer (Triple Negative Breast Cancer (TNBC))","enrollment":180},{"nctId":"NCT06399653","phase":"NA","title":"Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-01-01","conditions":"Alcohol Use Disorder","enrollment":80},{"nctId":"NCT06944145","phase":"PHASE2","title":"New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-12-03","conditions":"BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms","enrollment":242},{"nctId":"NCT03606070","phase":"NA","title":"Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study","status":"TERMINATED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2017-11-25","conditions":"NSCLC","enrollment":11},{"nctId":"NCT07488520","phase":"PHASE4","title":"Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire","status":"NOT_YET_RECRUITING","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2026-04","conditions":"Sickle Cell Disease (SCD)","enrollment":120},{"nctId":"NCT00338377","phase":"PHASE2","title":"Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-02-01","conditions":"Melanoma","enrollment":1230}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":18673,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"novel treatment","genericName":"novel treatment","companyName":"Imperial College London","companyId":"imperial-college-london","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This novel treatment works by targeting a specific molecular pathway to produce a therapeutic effect. Used for Metastatic non-small cell lung cancer, PD-L1 positive, Metastatic non-small cell lung cancer, PD-L1 negative.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}